← Open Payments lookup

MANUEL DOMAGTOY: Open Payments

NPI 1730511221 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$602 in 18 payments from 9 companies in 2025. Trend: 2023 $733 · 2024 $445 · 2025 $602

Food & beverage: $602
CompanyPaymentsAmount
Madrigal Pharmaceuticals2$156
Gilead Sciences, Inc.1$121
ABBVIE INC.4$76
Braintree Laboratories, Inc.2$67
Novo Nordisk Inc2$50
Ardelyx, Inc.2$47
PFIZER INC.2$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$33
Aimmune Therapeutics, Inc.1$18

Products named: REZDIFFRA, Livdelzi, SUFLAVE, LINZESS, IBSRELA, VELSIPITY, RELISTOR, Ozempic.

Industry payments across FL — which companies pay providers there.